| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Growth Officer | Chief Strategy Officer
1 company
Johnson Andrew L. serves as a Chief Growth Officer at PLSH. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $1.2M at current prices.
The biggest single holding is PLSH (~$1.2M) as Chief Growth Officer. Net of sales, the recent Form 4 record there shows accumulation of 62,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2019 | PLSH Panacea Life Sciences Holdings, Inc. | Chief Strategy Officer | Buy | 62,500 | $0.40 | $25,000.00 | +7.9% |